Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Chen, Frederick Y
NCT05002777 / 2021-001671-16: Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA) Jul 2024 - Dec 2024 : Data from trial for warm autoimmune hemolytic anemia	Active, not recruiting	2	22	Europe, US, RoW	rilzabrutinib, PRN1008/SAR444671	Sanofi, Sanofi Aventis Recherche et Developpement	Warm Autoimmune Hemolytic Anemia (wAIHA)	05/24	05/25